{"id":183168,"name":"CSL BEHRING LLC","slug":"csl-behring-llc","state":"PA","country":"United States of America","description":"","totalSpending":10160000,"filings":34,"yearlySpending":[{"year":2018,"income":780000},{"year":2019,"income":910000},{"year":2020,"income":1050000},{"year":2021,"income":1200000},{"year":2022,"income":1700000},{"year":2023,"income":980000},{"year":2024,"income":1320000},{"year":2025,"income":2220000}],"issues":[{"code":"TAX","display":"Taxation/Internal Revenue Code"},{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"HCR","display":"Health Issues"},{"code":"GOV","display":"Government Issues"},{"code":"IMM","display":"Immigration"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["CSL BEHRING LLC"],"lobbyists":["PATRICK COLLINS","JULIA GRANT","DENNIS JACKMAN","MARY REUTHER","COLLEEN MALONEY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Treasury, Dept of","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","Homeland Security, Dept of (DHS)","U.S. Customs & Border Protection"],"sampleDescriptions":["Follow-up legislation to tax reform","Renewal of the Office of Foreign Assets Control license for toll manufacturing of therapies for international distribution","H.R. 3178--Medicare Part B Improvement Act of 2017--Home infusion provision for DME administered drugs incorporated within the budget deal\nPreserving Access to Orphan Therapies Act--Exploration of fin","H.R. 4724--The Medicare IVIG Access Enhancement Act--Lobbied in support of this legislation that would create a home infusion benefit under Medicare Part B for IVIG when used in the treatment of CIDP.","Preserving Access to Orphan Drugs Act--Orphan Drugs Exclusion from the Branded Annual Pharmaceutical Fee"]}